566 related articles for article (PubMed ID: 8200909)
21. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
23. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
24. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
25. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
Henttu P; Vihko P
Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene.
Untawale S; Zorbas MA; Hodgson CP; Coffey RJ; Gallick GE; North SM; Wildrick DM; Olive M; Blick M; Yeoman LC
Cancer Res; 1993 Apr; 53(7):1630-6. PubMed ID: 8453634
[TBL] [Abstract][Full Text] [Related]
29. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
Fernandez-Pol JA
Crit Rev Oncog; 1991; 2(2):173-85. PubMed ID: 1677274
[TBL] [Abstract][Full Text] [Related]
30. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
31. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
32. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
Ariazi EA; Clark GM; Mertz JE
Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
[TBL] [Abstract][Full Text] [Related]
33. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
Arrick BA; Korc M; Derynck R
Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
38. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
39. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
Davidson NE; Prestigiacomo LJ; Hahm HA
Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822
[TBL] [Abstract][Full Text] [Related]
40. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]